Enhancing Electronic Health Record Measurement of Depression Severity and Suicide Ideation: A Distributed Ambulatory Research in Therapeutics Network (DARTNet) Study

References

1. 1.↵
   1. Kessler RC,
   2. Berglund P,
   3. Demler O,
   4. et al

   . The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–105.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Murray CJL,
   2. Lopez AD

   , eds. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. The Global Burden of Disease and Injury Series, no. 1. Cambridge, MA: Harvard School of Public Health, on behalf of the World Health Organization and the World Bank, Harvard University Press; 1996.
3. 3.↵
   1. Nease DE Jr.,
   2. Volk RJ,
   3. Cass AR

   . Does the severity of mood and anxiety symptoms predict health care utilization? J Fam Pract 1999;48:769–77.

   OpenUrlPubMedWeb of Science
4. 4.↵
   1. Blom MB,
   2. Spinhoven P,
   3. Hoffman T,
   4. et al

   . Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. J Affect Disord 2007;104:119–26.

   OpenUrlPubMed
5. 5.↵
   1. Thase ME,
   2. Simons AD,
   3. Cahalane J,
   4. McGeary J,
   5. Harden T

   . Severity of depression and response to cognitive behavior therapy. Am J Psychiatry 1991;148:784–9.

   OpenUrlPubMedWeb of Science
6. 6.↵
   1. Kroenke K,
   2. Spitzer RL

   . The PHQ-9: a new depression and diagnostic severity measure. Psychiatr Ann 2002;32:509–21.

   OpenUrlWeb of Science
7. 7.↵
   1. Goldsmith S,
   2. Pellmar T,
   3. Kleinman A,
   4. Bunney W

   , eds. Reducing Suicide: A National Imperative. Washington, DC: Institute of Medicine National Academies Press; 2002.
8. 8.↵
   1. Harris EC,
   2. Barraclough B

   . Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997;170:205–28.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Kroenke K,
   2. Spitzer RL,
   3. Williams JB

   . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Trivedi MH,
    2. Rush AJ,
    3. Ibrahim HM,
    4. et al

    . The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004;34:73–82.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. O'Connor EA,
    2. Whitlock EP,
    3. Beil TL,
    4. Gaynes BN

    . Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med 2009;151:793–803.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    Agency for Healthcare Research and Quality. Comparative Effectiveness of Second- Generation Antidepressants in the Pharmacologic Treatment of Adult Depression. In: Effective Health Care. Pub. No. 07-EHC007–1. Rockville, MD: AHRQ; 2007.
13. 13.↵
    1. Pace W,
    2. et al

    . Distributed Ambulatory Research in Therapeutics Network (DARTNet): summary report. July 2009, Prepared by University of Colorado DEcIDE Center under Contract No. HHSA 29020050037I-TO2. Rockville, MD: Agency for Healthcare Research and Quality. Available at: http://effectivehealthcare.ahrq.gov/ehc/products/53/151/2009_0728DEcIDE_DARTNet.pdf. Accessed December 4, 2010.
14. 14.↵
    1. Pace WD,
    2. Cifuentes M,
    3. Valuck RJ,
    4. et al

    . An electronic practice-based network for observational comparative effectiveness research. Ann Intern Med 2009;151:338–40.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    Agency for Health Care Research and Quality. Distributed Ambulatory Research in Therapeutics Network(DARTNet): Summary Report, Appendix A, pages A4–A8. Available at: http://effectivehealthcare.ahrq.gov/ehc/products/53/152/2009_0728DEcIDE_DARTNet_Appendices.pdf. Accessed December 4, 2010.
16. 16.↵
    National Committee for Quality Assurance. HEDIS volume 2: technical specifications. Washington, D.C.: National Committee for Quality Assurance; 2004.
17. 17.↵
    1. Scholle SH

    . NCQA behavioral health measurement efforts. J Managed Care Pharm 2005;11:S9–S11.

    OpenUrl
18. 18.↵
    1. Libby AM,
    2. Brent DA,
    3. Morrato EH,
    4. Orton HD,
    5. Allen R,
    6. Valuck RJ

    . Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007;164:884–91.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Valuck R,
    2. Libby AM,
    3. Orton HD,
    4. Morrato EH,
    5. Allen R,
    6. Baldessarini RJ

    . Spillover effects on treatment of adult depression in primary care after the FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 2007;164:1198–205.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Gaynes BN,
    2. Rush AJ,
    3. Trivedi MH,
    4. et al

    . Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Ann Fam Med 2007;5:126–34.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Kessler RC,
    2. Berglund P,
    3. Demler O,
    4. et al

    . The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–105.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Ormel J,
    2. Koeter MW,
    3. van den Brink W,
    4. et al

    . Recognition, management, and course of anxiety and depression in general practice. Arch Gen Psychiatry 1991;48:700–6.

    OpenUrlCrossRefPubMedWeb of Science